Vanta Bioscience (BOM:540729) Scaled Net Operating Assets : 0.88 (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Vanta Bioscience Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vanta Bioscience's operating assets for the quarter that ended in Sep. 2024 was ₹854.81 Mil. Vanta Bioscience's operating liabilities for the quarter that ended in Sep. 2024 was ₹104.81 Mil. Vanta Bioscience's Total Assets for the quarter that ended in Mar. 2024 was ₹853.97 Mil. Therefore, Vanta Bioscience's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.88.

Vanta Bioscience Scaled Net Operating Assets Historical Data

The historical data trend for Vanta Bioscience's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vanta Bioscience Scaled Net Operating Assets Chart

Vanta Bioscience Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

Get a 7-Day Free Trial

1.07

1.23

1.06

0.93

0.87

Vanta Bioscience Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial											0.88	0.91	0.90	0.87	0.88

Competitive Comparison of Vanta Bioscience's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, Vanta Bioscience's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vanta Bioscience's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vanta Bioscience's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Vanta Bioscience's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Vanta Bioscience Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vanta Bioscience's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(852.36	-	113.075)	/	847.091
=	0.87

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	853.966	-	1.606
=	852.36

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	724.233	-	488.014	-	123.144
=	113.075

Vanta Bioscience's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Mar. 2024 )
=	(854.811	-	104.81)	/	853.966
=	0.88

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	856.452	-	1.641
=	854.811

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	763.017	-	521.183	-	137.024
=	104.81

Vanta Bioscience Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Vanta Bioscience's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vanta Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vanta Bioscience Ltd (BOM:540729) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 02/G/308/G, Umajay Complex, No. 3/FF/SF/1-20-248, Rasoolpura, Secunderabad, TG, IND, 500003

Website

https://www.vantabio.com

Vanta Bioscience Ltd is a full-service preclinical contract research organization. It is engaged in the provision of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation services.

Vanta Bioscience Headlines

No Headlines